Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl-Peptidase IV Inhibitors”

167 trials

Showing 20 of 167 results

Post-approval studies (Phase 4)UnknownNCT02528019
What this trial is testing

Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

Who this might be right for
Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications
Kurume University 100
Post-approval studies (Phase 4)UnknownNCT00699322
What this trial is testing

Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress

Who this might be right for
Type 2 Diabetes
The Catholic University of Korea 36
Testing effectiveness (Phase 2)Study completedNCT06703268
What this trial is testing

A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Haisco Pharmaceutical Group Co., Ltd. 64
Testing effectiveness (Phase 2)Study completedNCT03922750
What this trial is testing

A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 154
Not applicableStudy completedNCT02792400
What this trial is testing

The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors

Who this might be right for
Type 2 Diabetes
University Hospital, Gentofte, Copenhagen 24
Not applicableStudy completedNCT02312375
What this trial is testing

Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients

Who this might be right for
Diabetes MellitusHypertension
Seoul National University Hospital 46
Post-approval studies (Phase 4)Study completedNCT02406443
What this trial is testing

The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion

Who this might be right for
Type 2 Diabetes
University Health Network, Toronto 36
Large-scale testing (Phase 3)Study completedNCT00968708
What this trial is testing

Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Who this might be right for
Diabetes Mellitus, Type 2Acute Coronary Syndrome
Takeda 5,380
Testing effectiveness (Phase 2)Study completedNCT04124484
What this trial is testing

DBPR108 Tablets in Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes Mellitus
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 276
Not applicableUnknownNCT05817097
What this trial is testing

Effect of Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA Database

Who this might be right for
Cerebral InfarctionInfarction, BrainDipeptidyl-Peptidase IV Inhibitors
Ajou University School of Medicine 22,119
Not applicableStudy completedNCT00881543
What this trial is testing

"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"

Who this might be right for
Diabetes Type 2
University of Sao Paulo General Hospital 45
Early research (Phase 1)Study completedNCT00888238
What this trial is testing

A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 12
Post-approval studies (Phase 4)Study completedNCT01378117
What this trial is testing

Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusHospitalizationHyperglycemia
Emory University 90
Testing effectiveness (Phase 2)Study completedNCT03951805
What this trial is testing

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 205
Post-approval studies (Phase 4)Study completedNCT04654676
What this trial is testing

DPP4 Inhibitor on Glycemic Variability

Who this might be right for
Diabetes Mellitus, Type 2
University Malaysia Sarawak 12
Large-scale testing (Phase 3)Enrolling By InvitationNCT07073768
What this trial is testing

Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients

Who this might be right for
Diabetes Mellitus Type 2Glycemic Control for Diabetes Mellitus
Khyber Medical College, Peshawar 126
Large-scale testing (Phase 3)Study completedNCT01137812
What this trial is testing

The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 756
Testing effectiveness (Phase 2)Ended earlyNCT00370942
What this trial is testing

GW823093C For The Treatment Of Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 159
Testing effectiveness (Phase 2)Study completedNCT03751657
What this trial is testing

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 247
Large-scale testing (Phase 3)Study completedNCT00690638
What this trial is testing

Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Phenomix 480
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation